Status | Study |
Completed |
Study Name: In-stent Restenosis in Patients With Patent Previous Bare Metal Stent Condition: In-stent Coronary Artery Restenosis Date: 2011-02-13 |
Completed |
Study Name: The Effects of Bindarit in Preventing Stent Restenosis Condition: Coronary Restenosis Date: 2011-01-03 Interventions: Drug: bindarit 300 mg bid, tha |
Completed |
Study Name: Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis Condition: In-stent Coronary Artery Restenosis Date: 2009-08-13 Interventions: Device: Paclitaxel Releasing Balloon Percutaneous coronary intervention with paclitaxel releasing balloo |
Completed |
Study Name: Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period Condition: Coronary Restenosis Date: 2009-04-14 Interventions: Device: Xience V® Placement of a Xience V® stent within a restenosed bare metal stent. |
Completed |
Study Name: Oral Sirolimus for In-Stent Restenosis Condition: Coronary Restenosis Date: 2009-03-06 Interventions: Drug: Sirolimus cumulative loa |
Completed |
Study Name: Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT) Condition: Coronary Restenosis Date: 2008-09-11 Interventions: Device: Milennium Matrix® (Control) |
Completed |
Study Name: SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents Condition: Coronary Artery Disease Coronary Restenosis Date: 2008-07-09 Interventions: Radiation: Intracoronary brachytherapy Beta irradiation with a 40-mm strontium/lytrium-90 source |
Completed |
Study Name: Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents Condition: Coronary Artery Disease Date: 2008-02-24 Interventions: Device: bare metal stent impla |
Completed |
Study Name: Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal Condition: Coronary Restenosis Date: 2007-12-26 |
Completed |
Study Name: Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial Condition: Angioplasty, Transluminal, Percutaneous Coronary Coronary Restenosis Date: 2007-07-10 Interventions: Drug: Celecoxib |